SlideShare a Scribd company logo
Daw Pyae Mon Kyaw
Department of Medical Laboratory Technology
University of Medical Technology, Mandalay
1
2
Discovery
 Karl Landsteiner(1990) discovered human A, B, O groups.
 Van Deacastello and Sturli (1902) discovered AB blood group.
 Von Sungern and Kirzsledl (1911) divided group A into 2 subgroups, A1 and A2.
ABO system is classified into 6 groups: A1, A2, A1B, A2B, B, AB and O.
3
Landsteiner’s Law
1. If an agglutinogen is present on red blood cell membrane, the corresponding agglutinin
must be absent in the plasma.
2. If an agglutinogen is absent on red blood cell membrane, the corresponding agglutinin
must be present in the plasma.
4
5
Immune system
6
Antigen
7
Antigen location
 Human antigens are found on cells, organs, and tissues as well as in plasma and
other body fluids.

protrude from cell surface
 Physical location - on cell membrane (eg. ABO ag)
integral part of the membrane
(eg. Rh Ag)
8
9
ABO antigen
 Blood group antigens are actually sugars attached to the red blood cell.
 Antigens are built onto the red cell.
 Individuals inherit a gene which codes for specific sugar to
be added to the red cell.
 The type of sugar added determines the blood group.
10
ABO Antigen
 Appear in the sixth week of fetal life and remain unchanged until death.
 Human red cells contain on their surface a series of glycoprotein and glycolipid 
blood group antigen
11
ABO Antibodies
Can be classified as
1. Naturally occurring and immune antibodies
Depending on presensitization
2. Complete and incomplete antibodies
Depends on aggulutination of saline suspended red cells
IgM is complete antibody, most naturally occurring antiboides are complete and of IgM class
Ig G is incomplete antibody
3. Cold and warm antibody
thermal range of antibodies
Most natural antibodies are cold and some e.g. wide thermal range like Anti A and Anti B
Most immune antibodies are warm and can destroy red cell in vivo
12
Naturally occurring antibodies
 Almost all normal healthy individuals above 3-6 months of age have “ Naturally
occurring antibodies” to the ABO antigens that they lack
 Peak at 5-10 yrs
 Decline progressively with advanced age.
 These Abs termed Naturally occurring because they were thought to arise without
antigenic stimulation.
 These naturally occurring Abs are mostly IgM class. That means that,they are Abs
capable of aggulutinating saline/low protein suspended red cell without
enhancement and may activate complement cascade.
13
Immune or acquired antibodies
 Produced as a result of stimulation by a red cell antigen which is not present on his
own red cell or in his body fluid.
 Arise from blood transfusion or the intravenous or intramuscular injection of blood
or injection of substances which are chemically closely related to a red cell antigen
or as a result of pregnancy.
 More often IgG
 Most importance in transfusion is IgG which can pass through the placenta during
pregnancy.
14
Complete antibody and incomplete antibody
Compete antibody
- produced without any antigenic stimulus
- most ofen IgM
- capable of aggulutinating red cells
suspended in normal saline at 20-25 C
Incomplete antibody
- requires a bridge like the Coomb’s sera
for bilnding to the antigenic site
- most IgG
15
16
Detection of antibodies
1. Saline aggulutination method
2. Albumin agglutination method
3. Test using enzyme treated cells
4. The indirect antiglobuliln (Coomb’s tsest)
17
Antigen-Antibody reaction
 Red cell Ag-Ab reaction can detected by a number of techniques
 Most frequently used
 Hemolysis
 Agglutination
 Used as indicator of Ag-Ab reaction
18
Agglutination Reactions
Two Stage Process:
Stage 1 Sensitization:
 attachment of Antibody to Antigen on the RBC membrane.
Stage 2 Lattice formation (agglutination):
 formation of bridges between the sensitized red cells to form the lattice that constitutes agglutination.
19
This represents what occurs during stage one of
agglutination.
• Antibody molecules attach to their corresponding
antigenic site (epitope) on the red blood cell membrane.
• There is no visible clumping.
• Red cells must be close enough for the Fab portion of
Ab to bind and make bridges between cells
Stage 1: Sensitization
20
Stage 2: Lattice Formation
This represents what occurs during stage 2 of agglutination:
Antibody molecules crosslink RBCs forming a lattice that
results in visible clumping or agglutination.
21
 Sensitization by IgG does not result in agglutination
 IgG is too small to span the distance between two red cells
 IgM can easily cause agglutination
 For agglutination to occur, the repulsive forces keeping red cells apart must be
overcome
22
23
The Zeta Potential
 The electric repulsion between cells
 This explains why cells do not agglutinate
 Red cells have negative charge due to
sialic acid molecules
 When red cells are in solution containing
free ions:
 Cations are attracted to the –vely charged red
cells
 This forms a repelling cloud around the cell
24
 The Zeta Potential can
be varied by altering the
charge on red cells
 This can affect both
sensitization and
agglutination
 Reducing the cloud
density allow Abs to
approach the cells,
sensitize and then
agglutinate them
25
26
3. Increase the ionic strength of the medium
 Increasing conc. of cations in medium cause
 Increase in the density of ions around the red cell which cause
 Size of cloud of cations is decreased
 Zeta potential decreases
 Red cell approach each other easily
 Agglutination is facilitated
27
4. Decreasing the ionic strength of medium by using low
ionic strength saline (LISS)
 Decreasing conc. of cations in medium
 Leads to decrease in density of ions around red cells
 This increases sensitization
 But decreases agglutination
28
Factors affecting Red Cell Sensitization
1. Ratio of Ab to Ag
 Sensitization occurs easily when at higher conc. of Ab
 This can be done by increasing conc. of serum containing
the Ab to conc. of cells
29
Factors affecting Red Cell Sensitization
2- The pH of reaction mixture
 At a pH below the pI, Abs have
+ve charges
 This makes it easier for the Ab
to bind to the –vely charged
red cells
 Optional pH for sensitization is
6.5 to 7.5 (Ab +vely charged)
pH 8 pH 7
30
3- Temperature
Ag- Ab reactions are exothermic
Therefore, Abs bind to a greater degree at lower temperature
But at lower temperatures, rate of reaction is reduced
To speed up reaction, tests are done at 37oC
31
 Temperature can also affect Ag accessibility on red cells
 Some IgM Abs bind best at 4oC (cold Abs)
 Temperature can make conformational changes in the Ag
 More Ag sites are exposed as the temperature is lowered allowing
increased binding of Ab
 Most naturally occurring cold Abs are of no clinical
significance
 Compatibility testing is done at 37C
4oC 37oC
32
4. Ionic strength of the medium
When RBCs are suspended in LISS the cloud of ions around
the cell is less dense than in isotonic saline
Reduced conc. of cations surrounding RBCs allow +vely
charged Abs easier to access Ag sites
Rate of sensitization increases
33
5- Antigen Density
 The greater the number of Ags on red cell, the greater the sensitization
 Binding of +vely charged Abs to red cells lower the zeta potential
 And therefore enhances agglutination
 Increased Ag density also increases chance of bridging
34
Factors Influencing RBCs Agglutination
6- Ag Clustering and Mobility
 Clustering facilitates agglutination by increasing likelihood of Ab binding at that
site
 Cluster of some Ags can occur after enzyme treatment of cells
Clustering of Ags
35
Factors Influencing RBCs Agglutination
7- Antibody Characteristics
 Ability of Ab to agglutinate cells depend on the Ig
class
 IgM has a wider span than IgG, and therefore more
effective agglutination
 IgG can be chemically modified to increase its span
IgMA
g
300 Ao
IgG IgG
150 Ao250-300 Ao
36
 8. Specificity
 9. Bonding
 10. Physical fit
 11. Incubation time
37
Genetics of ABO blood group system
38
Basic genetics of Blood group
39
ABH antigen
 Express on RBC, platelet, epithelial cells are mainly glycospingolipids
 Also present in body fluid (saliva, serum) are glycoproteins
 Genes ABO,Hh, Se control the expressions of antigens.
40
Location
 The presence or absence of the
ABH antigens on the red blood
cell membrane is controlled by
the H gene.
 The presence or absence of the
ABH antigens in secretions is
indirectly controlled by the Se
gene.
41
H antigen
 The H gene codes for an enzyme that adds sugar fucose to the terminal sugar of a
precursor substance
 The precursor substance (proteins and lipids) is formed on an oligosaccharide chain
(the basic structure)
42
43
H antigen
 Is the foundation upon which A and B
antigens are built.
 A and B genes code for enzyme that add
an immunodominant sugars to the H
antigen
 Immunodominant sugars are present at the
terminal ends of the chains and confer the ABO
antigen specificity
44
A antigen
 The A gene codes for an enzyme
(transferase) that adds N-
acetylgalactosamine to the terminal sugar of
the H antigen
 N-acetylgalactosaminyltransferase
45
B antigen
 The B gene codes for an enzyme that
adds D-galactose to the terminal sugar
of the H antigen
 D-galactosyltransferase
46
Formation of AB antigen
47
A, B and H
48
 Certain blood types possess more H antigen than others.
 Most H O>A2>B>A2B>A1>A1B
Least H

49
 Why do Group O individuals have more H
antigen than the other groups?
 Group O individuals have no A or B genes
to convert the H antigen that means more
H antigen sites
50
51
52
53
Bombay Phenotype (Oh)
 Inheritance of hh
 The h gene is an amorph and results in little or no production of L-fucosyltransferse
 Orginally found in Bombay
 Very rare (130 worldwide)
 The hh causes NO H antigen to be produces
 Results in RBCs with no H, A, or B antigen (patient type as O)
 Bombay RBC are NOT agglutinated with anti A, anti B,or anti H(no antigens present)
 Bombay serum has strong anti A, anti B and anti H, agglutinating ALL ABO blood
groups
54
 What blood ABO blood group would you use to transfuse this patient?
 Another Bombay
 Group O RBC cannot be given because they still have H antigen
 You have to transfuse the patient with blood that contains NO H antigen
55
Blood group Antigens on cell Antibodies in plasma
A A Anti-B
B B Anti-A
AB A and B Anti-AB
O None Anti A and B
56
57
Methods of Blood Grouping
 Several methods can be done for ABO grouping.
 Serology - direct detection of the ABO antigens. It is the main method
used in blood transfusion centre and hospital blood banks.
 This form of testing involves two componenets.
 1 Antibodies that are specific at detecting a particular ABO antigen on RBCs.
 2 Cells that are of a known ABO group that are agglutinated by the naturally occurring antibodies in
the person’s serum
58
Blood grouping
Blood grouping
Forward or cell
grouping or front typing
or forward typing
Reverse or serum
grouping or confirming
grouping or back
typing
59
Forward grouping
Test for antigens
 Patient’s cells containing unknown antigens tested with known antisera.
 Reaction of patient red blood cells tested with reagent anti A and anti B antisera
Forward
grouping
Slide
method
20-40% Patient’s RBC
suspension + known antiserum
Tube
method
2-5% Patient’s RBC suspension+
known antiserum(centrifuge before
read)
60
Forward group pattern
61
Reverse grouping
 Serum is combined with cells having known red cell content in a 2:1 ratio
Reverse
grouping
Slide
Method
20-40% Known red cell
suspension + patient’s serum
Tube
method
2-5% Known red cell suspension +
patient’s serum
62
Reverse grouping
 Reverse Group ; reaction pattern
63
64
65
Grade of agglultination
66
Use of Group O cells when carrying out a serum group
 Some donors have antibodies in their serum other than anti A or anti B
 These antibodies are not naturally expected to be present
 These are called irregular antibodies
 As a result of earlier immunization , during pregnancy in the case of a woman,
previous transfusion
 The presence of irregular antibodies may be demonstrated by using group O cell in
serum grouping
Viva,
MSQ
67
Subgroups of A (A1 and A2)
They both react strongly with reagent anti-A.
80% of group A individuals phenotype as A1
20% phenotype as A2
Reagent anti-A is a mixture of two Abs ;
anti-A which react with both A1 and A2 cells.
anti-A1 which reacts with A cells but not with A2 cells in simple testing .
68
Difference Between A1 and A2
 A1 has more A and less H antigen on the cell.
 A2 has less A and more H antigen
 Cannot be detected serologically
 A2 can produce anti- A1 – qualitative difference
69
Differentiation between the A blood subgroups
 Reagent anti-A is a mixture of two Abs
Anti-A1-lectin: is another source of anti-A1.
lectins are seed extracts that agglutinate human cells with some degree of specificity.
The seeds of the plant Dolichos biflorus serve as the source of the anti-A1 lectin this
reagent agglutinate A1 or A1B cells but does not agglutinate A2 or A2B cells.
70
Anti-A1
 1-8% of A2 and 22-35% of A2B people will have anti-A1
 Causes ABO discrepancy – reverse type
 Incompatible crossmatch if donor A1
 NOT clinically significant unless reactive at 37C or AHG.
 Clinically significant – ability to cause red cell destruction – donor blood or
hemolytic disease of the fetus and newborn.
71
Subgroup A Subgroup frequency Antibodies always
present
Antibodies sometimes
present
A1 80% Anti B None
A2 20% Anti B Anti A1 in 2%
A1B 80% None None
A2B 20% none Anti A1 in 25%
72
Anti AB
 Used anti AB as a part of standard blood grouping to ensure weak A and B antigen
 This mixture has a much higher affinity for weaker antigens
 Not required for testing patient’s red cells
 Recommended for donor blood grouping
73
Anti A
 Consist of a mixture of two antibodies.
 Anti A  agglutinates A1, A2, A1B, A2B cells
 Anti A1 agglutinates only A1 and A1B cells
74
Secretor Genes
 A, B and H antigens may be present in fluids.
 Controlled by Se and se, secretor genes.
 Need only one copy of the Se gene.
 The gene se is an amorph.
 Not linked to ABO locus, inherited independently
75
76
Secretor Genes
 Persons who have A, B and/or H in secretions are called “secretors”
Blood Group Substance in Secretions
A A and H
B B and H
AB A, B and H
O H
77
ABO & Rh D Grouping using Tile Technique
Anti A Anti B Anti AB A cell B cell Ocell Anti D
Patient ID
Patient ID
Patient ID
The blood group reagents should be dispesne according to the
labeling on the tile.
Reagents
 Place one drop of anti A reagent in each of the wells in the
anti A columm.
 Place one drop of anti B reagent in each of the wells in the
anti B columm. 78
 Place one drop of anti AB reagent in each of the wells in the anti AB columm.
 Place one drop of A cells (15-20% reverse cells) in each of the wells in the anti A cells column.
 Place one drop of B cells (15-20% reverse cells) in each of the wells in the anti B cells
column.
 Place one drop of O cells (15-20% reverse cells) in each of the wells in the anti O cells
column.
 Place one drop of anti D reagent in each of the wells in the anti D column.
79
 Samples
 For each row:
 Place one drop of 15-20% patient cells in each of the anti A, anti B, anti AB and anti D wells.
 Place two drops of patient plasma (or serum) in each of the A cells, B cells and O cells wells.

 Procedure
 Mix the contents of all wells using the wooden mixing "sticks".
 Gently rock the tile and then place at room temperature.
 Examine for agglutination after 5 minutes.
 If a weak agglutination or negative reaction is obtained, examine again after 15 minutes.
 Using the Agglutination Grading chart as a guide, score the results for each well from 0-4+.
 Determine the group for the control and patient samples using the Tile Group Interpretation Chart.
80
ABO & RhD Grouping Using Tube Technique
 Principle
 The ABO forward group identifies the presence or absence of ABO antigens on the red cell
surface using antibodies to those antigens. The ABO reverse group identifies the presence
or absence of naturally occurring plasma (or serum) antibodies to ABO groups must
correlate.
 The Rh system is the second most important blood group system. Blood is classified as Rh
D positive or RhD negative depending on the presence or absence of the Rh D blood group
antigen.
 A weakened expression of the Rh D antigen may occasionally be present on red cells.
 Approximately 82% of the Caucasian populations are Rh D positive.
 The ABO and Rh D blood groups of blood donors and recipients are routinely determined
to ensure that ABO and Rh D compatible blood is used for transfusion.
 All blood group discrepancies must be resolved.
 This procedure describes ABO and Rh D grouping tests, using test tube based techniques.

81
 Specimen preparation
 A 3-5% red cell suspension of test cells and a separated sample of patient serum (or) plasma are
required.
 Materials
 Patient 3-5% red cell suspension
 Patient plasma or serum
 ABO forward Group Typing Reagents
 ABO Reverse Grouping Reagents Red Cells
 Reverse cell 3% cells
 Rh D Blood Grouping Reagents
 Anti D
 Buffered saline or Normal saline
 Plastic Pipettes
82
 suitable centrifuge
 Light Box
 Grading Chart
83
 Procedure
 The ABO cell (forward) and plasma or serum (reverse) groups and Rh D group are performed simultaneously.
 Prepare a 3-5% suspension of patient red cells as per SOP (1).
 Label 7 glass test tubes (12x75 mm) with a unique patient identifer and anti A, anti B, anti AB and anti D for
cell grouping (forward group) and A cells, B cells and O cells for plasma grouping (reverse group).
 Place two drops of patient plasma into the two tubes labeled A cells, B cells and O cells.
 Place one drop of each grouping reagent into the appropriate tubes.
 Add one drop of 3-5% test red cell suspension to each of the four tubes containing the forward grouping
reagents and add one drop of A1 and B reagent red cells (Revercells) to the 3 tubes labeled A cells, B cells
and O cells.
 Gently shake all tubes to allow mixing and incubate at room temperature for 5 minutes.
 Centrifuge tubes at 2000 rpm for 15 seconds or 1000 rpm for 1 minute using Immufuge or another suitable
centrifuge.
 Examine for macroscopic agglutination over a light box using the roll and tip method.
 Score and record results and interpretation on supplied worksheet.
84
Causes of False Positive Reaction
 1. Rouleaux formation
-pseudo agg  pile of coins due to high protein concentration
- can be differentiated from true agglutination by saline dispensing technique
2. Cold agglutinin  cause auto agg, active at RT. If suspected,
- serum grouping  repeated at 37C
- cell grouping  repeated after washing several time in warm buffered
saline
3. Infected red cells
- poly agg – less obvious – does not occur at 37C- true group can be
done at 37C
85
Cause of False negative reaction
 1 Use of impotent sera
 Loss of potency result if sera are left at RT or stored frozen in large volume
 2. No recognition of lysis
 Inspected for lysis
86

More Related Content

What's hot

OTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSOTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSFerdie Fatiga
 
Forward and reverse grouping by Negash Alamin
Forward and reverse grouping  by Negash AlaminForward and reverse grouping  by Negash Alamin
Forward and reverse grouping by Negash Alamin
Negash Alamin
 
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM ‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
Naglaa Makram
 
Cross matching
Cross matchingCross matching
Cross matching
Mitalisingh30
 
Ab identificationreneewilkins
Ab identificationreneewilkinsAb identificationreneewilkins
Ab identificationreneewilkins
muhammad arif
 
Abo blood groups
Abo blood groupsAbo blood groups
Abo blood groups
dr yogendra vijay
 
Osmotic fragility test
Osmotic fragility testOsmotic fragility test
Osmotic fragility test
fateh11
 
ABO Blood Group System.pptx
ABO  Blood Group System.pptxABO  Blood Group System.pptx
ABO Blood Group System.pptx
sandeep singh
 
Abo blood grouping
Abo blood groupingAbo blood grouping
Abo blood grouping
Tagore medical College
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
Dr Siddartha
 
Abo blood grp
Abo blood grpAbo blood grp
Abo blood grp
Niaz Ahammed
 
blood group du testing
blood group du testing blood group du testing
blood group du testing
rajesh kumar
 
Rbc count
Rbc countRbc count
Rbc count
ruchivss
 
Automated blood cell counter by yasin arafat
Automated blood cell counter by yasin arafatAutomated blood cell counter by yasin arafat
Automated blood cell counter by yasin arafat
Yasin Arafat
 
Differential Leukocyte Counts
Differential Leukocyte Counts Differential Leukocyte Counts
Differential Leukocyte Counts
Mobasshir Rahman
 
Rbc abnormality
Rbc abnormalityRbc abnormality
Rbc abnormality
Bhaikaka University
 
Crossmatching
CrossmatchingCrossmatching
Crossmatching
Sivaranjini N
 

What's hot (20)

OTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSOTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMS
 
Forward and reverse grouping by Negash Alamin
Forward and reverse grouping  by Negash AlaminForward and reverse grouping  by Negash Alamin
Forward and reverse grouping by Negash Alamin
 
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM ‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
 
Cross matching
Cross matchingCross matching
Cross matching
 
Ab identificationreneewilkins
Ab identificationreneewilkinsAb identificationreneewilkins
Ab identificationreneewilkins
 
Abo blood groups
Abo blood groupsAbo blood groups
Abo blood groups
 
Compatibility testing
Compatibility testingCompatibility testing
Compatibility testing
 
Osmotic fragility test
Osmotic fragility testOsmotic fragility test
Osmotic fragility test
 
ABO Blood Group System.pptx
ABO  Blood Group System.pptxABO  Blood Group System.pptx
ABO Blood Group System.pptx
 
Abo blood grouping
Abo blood groupingAbo blood grouping
Abo blood grouping
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
 
Abo blood grp
Abo blood grpAbo blood grp
Abo blood grp
 
blood group du testing
blood group du testing blood group du testing
blood group du testing
 
Rbc count
Rbc countRbc count
Rbc count
 
Automated blood cell counter by yasin arafat
Automated blood cell counter by yasin arafatAutomated blood cell counter by yasin arafat
Automated blood cell counter by yasin arafat
 
Differential Leukocyte Counts
Differential Leukocyte Counts Differential Leukocyte Counts
Differential Leukocyte Counts
 
Rbc abnormality
Rbc abnormalityRbc abnormality
Rbc abnormality
 
Crossmatching
CrossmatchingCrossmatching
Crossmatching
 
Le cell
Le cellLe cell
Le cell
 
Myeloperoxidases Stains
Myeloperoxidases StainsMyeloperoxidases Stains
Myeloperoxidases Stains
 

Similar to ABO blood group system

ANTIGEN -ANTIBODY REACTION pharm D second year
ANTIGEN -ANTIBODY REACTION pharm D second yearANTIGEN -ANTIBODY REACTION pharm D second year
ANTIGEN -ANTIBODY REACTION pharm D second year
abhiramiajith0203
 
Agglutination reactions
Agglutination reactionsAgglutination reactions
Agglutination reactions
Yeyeh Santos
 
Blood Typing Lab Report
Blood Typing Lab ReportBlood Typing Lab Report
Blood Typing Lab Report
Aimee Brown
 
Blood group 1
Blood group 1 Blood group 1
Blood group 1
Veena Shriram
 
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
LamaZein3
 
Transfusion medicine 2
Transfusion medicine 2Transfusion medicine 2
Transfusion medicine 2
Prof. Ahmed Mohamed Badheeb
 
Serology ppt by shery
Serology ppt by sherySerology ppt by shery
Serology ppt by shery
shehryar khan
 
ANTIGEN-ANTIBODY REACTION (in vitro)
ANTIGEN-ANTIBODY REACTION (in vitro)ANTIGEN-ANTIBODY REACTION (in vitro)
ANTIGEN-ANTIBODY REACTION (in vitro)
NITISH SHAH
 
Antigen ab reactions
Antigen ab reactionsAntigen ab reactions
Antigen ab reactionsBruno Mmassy
 
Antibodies
AntibodiesAntibodies
Antibodies
SHRUTHI VASAN
 
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCEAntigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
DR.PRINCE C P
 
DAT.ppt
DAT.pptDAT.ppt
DAT.ppt
maryamiqbal36
 
ABO blood.pptx
ABO blood.pptxABO blood.pptx
ABO blood.pptx
sandeep singh
 
Immunology and cell culture techniques
Immunology and cell culture techniquesImmunology and cell culture techniques
Immunology and cell culture techniques
MSCW Mysore
 
Serological tests
Serological testsSerological tests
Serological testsjessicaeo
 
Chapter2 immuno lab presentation
Chapter2 immuno lab presentationChapter2 immuno lab presentation
Chapter2 immuno lab presentationWisanu Wanasawaeng
 
antigen and antibody reactions- Immunology
antigen and antibody reactions- Immunologyantigen and antibody reactions- Immunology
antigen and antibody reactions- Immunology
DrShinyKajal
 
Crossmaching in the blood bank.pptx
Crossmaching in the blood bank.pptxCrossmaching in the blood bank.pptx
Crossmaching in the blood bank.pptx
George Suollo
 

Similar to ABO blood group system (20)

ANTIGEN -ANTIBODY REACTION pharm D second year
ANTIGEN -ANTIBODY REACTION pharm D second yearANTIGEN -ANTIBODY REACTION pharm D second year
ANTIGEN -ANTIBODY REACTION pharm D second year
 
Agglutination reactions
Agglutination reactionsAgglutination reactions
Agglutination reactions
 
Blood Typing Lab Report
Blood Typing Lab ReportBlood Typing Lab Report
Blood Typing Lab Report
 
Blood group 1
Blood group 1 Blood group 1
Blood group 1
 
Antigen Antibody techniques 6 lecture
Antigen Antibody techniques 6 lectureAntigen Antibody techniques 6 lecture
Antigen Antibody techniques 6 lecture
 
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
 
Transfusion medicine 2
Transfusion medicine 2Transfusion medicine 2
Transfusion medicine 2
 
Immunohema
ImmunohemaImmunohema
Immunohema
 
Serology ppt by shery
Serology ppt by sherySerology ppt by shery
Serology ppt by shery
 
ANTIGEN-ANTIBODY REACTION (in vitro)
ANTIGEN-ANTIBODY REACTION (in vitro)ANTIGEN-ANTIBODY REACTION (in vitro)
ANTIGEN-ANTIBODY REACTION (in vitro)
 
Antigen ab reactions
Antigen ab reactionsAntigen ab reactions
Antigen ab reactions
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCEAntigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCE
 
DAT.ppt
DAT.pptDAT.ppt
DAT.ppt
 
ABO blood.pptx
ABO blood.pptxABO blood.pptx
ABO blood.pptx
 
Immunology and cell culture techniques
Immunology and cell culture techniquesImmunology and cell culture techniques
Immunology and cell culture techniques
 
Serological tests
Serological testsSerological tests
Serological tests
 
Chapter2 immuno lab presentation
Chapter2 immuno lab presentationChapter2 immuno lab presentation
Chapter2 immuno lab presentation
 
antigen and antibody reactions- Immunology
antigen and antibody reactions- Immunologyantigen and antibody reactions- Immunology
antigen and antibody reactions- Immunology
 
Crossmaching in the blood bank.pptx
Crossmaching in the blood bank.pptxCrossmaching in the blood bank.pptx
Crossmaching in the blood bank.pptx
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 

ABO blood group system

  • 1. Daw Pyae Mon Kyaw Department of Medical Laboratory Technology University of Medical Technology, Mandalay 1
  • 2. 2
  • 3. Discovery  Karl Landsteiner(1990) discovered human A, B, O groups.  Van Deacastello and Sturli (1902) discovered AB blood group.  Von Sungern and Kirzsledl (1911) divided group A into 2 subgroups, A1 and A2. ABO system is classified into 6 groups: A1, A2, A1B, A2B, B, AB and O. 3
  • 4. Landsteiner’s Law 1. If an agglutinogen is present on red blood cell membrane, the corresponding agglutinin must be absent in the plasma. 2. If an agglutinogen is absent on red blood cell membrane, the corresponding agglutinin must be present in the plasma. 4
  • 5. 5
  • 8. Antigen location  Human antigens are found on cells, organs, and tissues as well as in plasma and other body fluids.  protrude from cell surface  Physical location - on cell membrane (eg. ABO ag) integral part of the membrane (eg. Rh Ag) 8
  • 9. 9
  • 10. ABO antigen  Blood group antigens are actually sugars attached to the red blood cell.  Antigens are built onto the red cell.  Individuals inherit a gene which codes for specific sugar to be added to the red cell.  The type of sugar added determines the blood group. 10
  • 11. ABO Antigen  Appear in the sixth week of fetal life and remain unchanged until death.  Human red cells contain on their surface a series of glycoprotein and glycolipid  blood group antigen 11
  • 12. ABO Antibodies Can be classified as 1. Naturally occurring and immune antibodies Depending on presensitization 2. Complete and incomplete antibodies Depends on aggulutination of saline suspended red cells IgM is complete antibody, most naturally occurring antiboides are complete and of IgM class Ig G is incomplete antibody 3. Cold and warm antibody thermal range of antibodies Most natural antibodies are cold and some e.g. wide thermal range like Anti A and Anti B Most immune antibodies are warm and can destroy red cell in vivo 12
  • 13. Naturally occurring antibodies  Almost all normal healthy individuals above 3-6 months of age have “ Naturally occurring antibodies” to the ABO antigens that they lack  Peak at 5-10 yrs  Decline progressively with advanced age.  These Abs termed Naturally occurring because they were thought to arise without antigenic stimulation.  These naturally occurring Abs are mostly IgM class. That means that,they are Abs capable of aggulutinating saline/low protein suspended red cell without enhancement and may activate complement cascade. 13
  • 14. Immune or acquired antibodies  Produced as a result of stimulation by a red cell antigen which is not present on his own red cell or in his body fluid.  Arise from blood transfusion or the intravenous or intramuscular injection of blood or injection of substances which are chemically closely related to a red cell antigen or as a result of pregnancy.  More often IgG  Most importance in transfusion is IgG which can pass through the placenta during pregnancy. 14
  • 15. Complete antibody and incomplete antibody Compete antibody - produced without any antigenic stimulus - most ofen IgM - capable of aggulutinating red cells suspended in normal saline at 20-25 C Incomplete antibody - requires a bridge like the Coomb’s sera for bilnding to the antigenic site - most IgG 15
  • 16. 16
  • 17. Detection of antibodies 1. Saline aggulutination method 2. Albumin agglutination method 3. Test using enzyme treated cells 4. The indirect antiglobuliln (Coomb’s tsest) 17
  • 18. Antigen-Antibody reaction  Red cell Ag-Ab reaction can detected by a number of techniques  Most frequently used  Hemolysis  Agglutination  Used as indicator of Ag-Ab reaction 18
  • 19. Agglutination Reactions Two Stage Process: Stage 1 Sensitization:  attachment of Antibody to Antigen on the RBC membrane. Stage 2 Lattice formation (agglutination):  formation of bridges between the sensitized red cells to form the lattice that constitutes agglutination. 19
  • 20. This represents what occurs during stage one of agglutination. • Antibody molecules attach to their corresponding antigenic site (epitope) on the red blood cell membrane. • There is no visible clumping. • Red cells must be close enough for the Fab portion of Ab to bind and make bridges between cells Stage 1: Sensitization 20
  • 21. Stage 2: Lattice Formation This represents what occurs during stage 2 of agglutination: Antibody molecules crosslink RBCs forming a lattice that results in visible clumping or agglutination. 21
  • 22.  Sensitization by IgG does not result in agglutination  IgG is too small to span the distance between two red cells  IgM can easily cause agglutination  For agglutination to occur, the repulsive forces keeping red cells apart must be overcome 22
  • 23. 23
  • 24. The Zeta Potential  The electric repulsion between cells  This explains why cells do not agglutinate  Red cells have negative charge due to sialic acid molecules  When red cells are in solution containing free ions:  Cations are attracted to the –vely charged red cells  This forms a repelling cloud around the cell 24
  • 25.  The Zeta Potential can be varied by altering the charge on red cells  This can affect both sensitization and agglutination  Reducing the cloud density allow Abs to approach the cells, sensitize and then agglutinate them 25
  • 26. 26
  • 27. 3. Increase the ionic strength of the medium  Increasing conc. of cations in medium cause  Increase in the density of ions around the red cell which cause  Size of cloud of cations is decreased  Zeta potential decreases  Red cell approach each other easily  Agglutination is facilitated 27
  • 28. 4. Decreasing the ionic strength of medium by using low ionic strength saline (LISS)  Decreasing conc. of cations in medium  Leads to decrease in density of ions around red cells  This increases sensitization  But decreases agglutination 28
  • 29. Factors affecting Red Cell Sensitization 1. Ratio of Ab to Ag  Sensitization occurs easily when at higher conc. of Ab  This can be done by increasing conc. of serum containing the Ab to conc. of cells 29
  • 30. Factors affecting Red Cell Sensitization 2- The pH of reaction mixture  At a pH below the pI, Abs have +ve charges  This makes it easier for the Ab to bind to the –vely charged red cells  Optional pH for sensitization is 6.5 to 7.5 (Ab +vely charged) pH 8 pH 7 30
  • 31. 3- Temperature Ag- Ab reactions are exothermic Therefore, Abs bind to a greater degree at lower temperature But at lower temperatures, rate of reaction is reduced To speed up reaction, tests are done at 37oC 31
  • 32.  Temperature can also affect Ag accessibility on red cells  Some IgM Abs bind best at 4oC (cold Abs)  Temperature can make conformational changes in the Ag  More Ag sites are exposed as the temperature is lowered allowing increased binding of Ab  Most naturally occurring cold Abs are of no clinical significance  Compatibility testing is done at 37C 4oC 37oC 32
  • 33. 4. Ionic strength of the medium When RBCs are suspended in LISS the cloud of ions around the cell is less dense than in isotonic saline Reduced conc. of cations surrounding RBCs allow +vely charged Abs easier to access Ag sites Rate of sensitization increases 33
  • 34. 5- Antigen Density  The greater the number of Ags on red cell, the greater the sensitization  Binding of +vely charged Abs to red cells lower the zeta potential  And therefore enhances agglutination  Increased Ag density also increases chance of bridging 34
  • 35. Factors Influencing RBCs Agglutination 6- Ag Clustering and Mobility  Clustering facilitates agglutination by increasing likelihood of Ab binding at that site  Cluster of some Ags can occur after enzyme treatment of cells Clustering of Ags 35
  • 36. Factors Influencing RBCs Agglutination 7- Antibody Characteristics  Ability of Ab to agglutinate cells depend on the Ig class  IgM has a wider span than IgG, and therefore more effective agglutination  IgG can be chemically modified to increase its span IgMA g 300 Ao IgG IgG 150 Ao250-300 Ao 36
  • 37.  8. Specificity  9. Bonding  10. Physical fit  11. Incubation time 37
  • 38. Genetics of ABO blood group system 38
  • 39. Basic genetics of Blood group 39
  • 40. ABH antigen  Express on RBC, platelet, epithelial cells are mainly glycospingolipids  Also present in body fluid (saliva, serum) are glycoproteins  Genes ABO,Hh, Se control the expressions of antigens. 40
  • 41. Location  The presence or absence of the ABH antigens on the red blood cell membrane is controlled by the H gene.  The presence or absence of the ABH antigens in secretions is indirectly controlled by the Se gene. 41
  • 42. H antigen  The H gene codes for an enzyme that adds sugar fucose to the terminal sugar of a precursor substance  The precursor substance (proteins and lipids) is formed on an oligosaccharide chain (the basic structure) 42
  • 43. 43
  • 44. H antigen  Is the foundation upon which A and B antigens are built.  A and B genes code for enzyme that add an immunodominant sugars to the H antigen  Immunodominant sugars are present at the terminal ends of the chains and confer the ABO antigen specificity 44
  • 45. A antigen  The A gene codes for an enzyme (transferase) that adds N- acetylgalactosamine to the terminal sugar of the H antigen  N-acetylgalactosaminyltransferase 45
  • 46. B antigen  The B gene codes for an enzyme that adds D-galactose to the terminal sugar of the H antigen  D-galactosyltransferase 46
  • 47. Formation of AB antigen 47
  • 48. A, B and H 48
  • 49.  Certain blood types possess more H antigen than others.  Most H O>A2>B>A2B>A1>A1B Least H  49
  • 50.  Why do Group O individuals have more H antigen than the other groups?  Group O individuals have no A or B genes to convert the H antigen that means more H antigen sites 50
  • 51. 51
  • 52. 52
  • 53. 53
  • 54. Bombay Phenotype (Oh)  Inheritance of hh  The h gene is an amorph and results in little or no production of L-fucosyltransferse  Orginally found in Bombay  Very rare (130 worldwide)  The hh causes NO H antigen to be produces  Results in RBCs with no H, A, or B antigen (patient type as O)  Bombay RBC are NOT agglutinated with anti A, anti B,or anti H(no antigens present)  Bombay serum has strong anti A, anti B and anti H, agglutinating ALL ABO blood groups 54
  • 55.  What blood ABO blood group would you use to transfuse this patient?  Another Bombay  Group O RBC cannot be given because they still have H antigen  You have to transfuse the patient with blood that contains NO H antigen 55
  • 56. Blood group Antigens on cell Antibodies in plasma A A Anti-B B B Anti-A AB A and B Anti-AB O None Anti A and B 56
  • 57. 57
  • 58. Methods of Blood Grouping  Several methods can be done for ABO grouping.  Serology - direct detection of the ABO antigens. It is the main method used in blood transfusion centre and hospital blood banks.  This form of testing involves two componenets.  1 Antibodies that are specific at detecting a particular ABO antigen on RBCs.  2 Cells that are of a known ABO group that are agglutinated by the naturally occurring antibodies in the person’s serum 58
  • 59. Blood grouping Blood grouping Forward or cell grouping or front typing or forward typing Reverse or serum grouping or confirming grouping or back typing 59
  • 60. Forward grouping Test for antigens  Patient’s cells containing unknown antigens tested with known antisera.  Reaction of patient red blood cells tested with reagent anti A and anti B antisera Forward grouping Slide method 20-40% Patient’s RBC suspension + known antiserum Tube method 2-5% Patient’s RBC suspension+ known antiserum(centrifuge before read) 60
  • 62. Reverse grouping  Serum is combined with cells having known red cell content in a 2:1 ratio Reverse grouping Slide Method 20-40% Known red cell suspension + patient’s serum Tube method 2-5% Known red cell suspension + patient’s serum 62
  • 63. Reverse grouping  Reverse Group ; reaction pattern 63
  • 64. 64
  • 65. 65
  • 67. Use of Group O cells when carrying out a serum group  Some donors have antibodies in their serum other than anti A or anti B  These antibodies are not naturally expected to be present  These are called irregular antibodies  As a result of earlier immunization , during pregnancy in the case of a woman, previous transfusion  The presence of irregular antibodies may be demonstrated by using group O cell in serum grouping Viva, MSQ 67
  • 68. Subgroups of A (A1 and A2) They both react strongly with reagent anti-A. 80% of group A individuals phenotype as A1 20% phenotype as A2 Reagent anti-A is a mixture of two Abs ; anti-A which react with both A1 and A2 cells. anti-A1 which reacts with A cells but not with A2 cells in simple testing . 68
  • 69. Difference Between A1 and A2  A1 has more A and less H antigen on the cell.  A2 has less A and more H antigen  Cannot be detected serologically  A2 can produce anti- A1 – qualitative difference 69
  • 70. Differentiation between the A blood subgroups  Reagent anti-A is a mixture of two Abs Anti-A1-lectin: is another source of anti-A1. lectins are seed extracts that agglutinate human cells with some degree of specificity. The seeds of the plant Dolichos biflorus serve as the source of the anti-A1 lectin this reagent agglutinate A1 or A1B cells but does not agglutinate A2 or A2B cells. 70
  • 71. Anti-A1  1-8% of A2 and 22-35% of A2B people will have anti-A1  Causes ABO discrepancy – reverse type  Incompatible crossmatch if donor A1  NOT clinically significant unless reactive at 37C or AHG.  Clinically significant – ability to cause red cell destruction – donor blood or hemolytic disease of the fetus and newborn. 71
  • 72. Subgroup A Subgroup frequency Antibodies always present Antibodies sometimes present A1 80% Anti B None A2 20% Anti B Anti A1 in 2% A1B 80% None None A2B 20% none Anti A1 in 25% 72
  • 73. Anti AB  Used anti AB as a part of standard blood grouping to ensure weak A and B antigen  This mixture has a much higher affinity for weaker antigens  Not required for testing patient’s red cells  Recommended for donor blood grouping 73
  • 74. Anti A  Consist of a mixture of two antibodies.  Anti A  agglutinates A1, A2, A1B, A2B cells  Anti A1 agglutinates only A1 and A1B cells 74
  • 75. Secretor Genes  A, B and H antigens may be present in fluids.  Controlled by Se and se, secretor genes.  Need only one copy of the Se gene.  The gene se is an amorph.  Not linked to ABO locus, inherited independently 75
  • 76. 76
  • 77. Secretor Genes  Persons who have A, B and/or H in secretions are called “secretors” Blood Group Substance in Secretions A A and H B B and H AB A, B and H O H 77
  • 78. ABO & Rh D Grouping using Tile Technique Anti A Anti B Anti AB A cell B cell Ocell Anti D Patient ID Patient ID Patient ID The blood group reagents should be dispesne according to the labeling on the tile. Reagents  Place one drop of anti A reagent in each of the wells in the anti A columm.  Place one drop of anti B reagent in each of the wells in the anti B columm. 78
  • 79.  Place one drop of anti AB reagent in each of the wells in the anti AB columm.  Place one drop of A cells (15-20% reverse cells) in each of the wells in the anti A cells column.  Place one drop of B cells (15-20% reverse cells) in each of the wells in the anti B cells column.  Place one drop of O cells (15-20% reverse cells) in each of the wells in the anti O cells column.  Place one drop of anti D reagent in each of the wells in the anti D column. 79
  • 80.  Samples  For each row:  Place one drop of 15-20% patient cells in each of the anti A, anti B, anti AB and anti D wells.  Place two drops of patient plasma (or serum) in each of the A cells, B cells and O cells wells.   Procedure  Mix the contents of all wells using the wooden mixing "sticks".  Gently rock the tile and then place at room temperature.  Examine for agglutination after 5 minutes.  If a weak agglutination or negative reaction is obtained, examine again after 15 minutes.  Using the Agglutination Grading chart as a guide, score the results for each well from 0-4+.  Determine the group for the control and patient samples using the Tile Group Interpretation Chart. 80
  • 81. ABO & RhD Grouping Using Tube Technique  Principle  The ABO forward group identifies the presence or absence of ABO antigens on the red cell surface using antibodies to those antigens. The ABO reverse group identifies the presence or absence of naturally occurring plasma (or serum) antibodies to ABO groups must correlate.  The Rh system is the second most important blood group system. Blood is classified as Rh D positive or RhD negative depending on the presence or absence of the Rh D blood group antigen.  A weakened expression of the Rh D antigen may occasionally be present on red cells.  Approximately 82% of the Caucasian populations are Rh D positive.  The ABO and Rh D blood groups of blood donors and recipients are routinely determined to ensure that ABO and Rh D compatible blood is used for transfusion.  All blood group discrepancies must be resolved.  This procedure describes ABO and Rh D grouping tests, using test tube based techniques.  81
  • 82.  Specimen preparation  A 3-5% red cell suspension of test cells and a separated sample of patient serum (or) plasma are required.  Materials  Patient 3-5% red cell suspension  Patient plasma or serum  ABO forward Group Typing Reagents  ABO Reverse Grouping Reagents Red Cells  Reverse cell 3% cells  Rh D Blood Grouping Reagents  Anti D  Buffered saline or Normal saline  Plastic Pipettes 82
  • 83.  suitable centrifuge  Light Box  Grading Chart 83
  • 84.  Procedure  The ABO cell (forward) and plasma or serum (reverse) groups and Rh D group are performed simultaneously.  Prepare a 3-5% suspension of patient red cells as per SOP (1).  Label 7 glass test tubes (12x75 mm) with a unique patient identifer and anti A, anti B, anti AB and anti D for cell grouping (forward group) and A cells, B cells and O cells for plasma grouping (reverse group).  Place two drops of patient plasma into the two tubes labeled A cells, B cells and O cells.  Place one drop of each grouping reagent into the appropriate tubes.  Add one drop of 3-5% test red cell suspension to each of the four tubes containing the forward grouping reagents and add one drop of A1 and B reagent red cells (Revercells) to the 3 tubes labeled A cells, B cells and O cells.  Gently shake all tubes to allow mixing and incubate at room temperature for 5 minutes.  Centrifuge tubes at 2000 rpm for 15 seconds or 1000 rpm for 1 minute using Immufuge or another suitable centrifuge.  Examine for macroscopic agglutination over a light box using the roll and tip method.  Score and record results and interpretation on supplied worksheet. 84
  • 85. Causes of False Positive Reaction  1. Rouleaux formation -pseudo agg  pile of coins due to high protein concentration - can be differentiated from true agglutination by saline dispensing technique 2. Cold agglutinin  cause auto agg, active at RT. If suspected, - serum grouping  repeated at 37C - cell grouping  repeated after washing several time in warm buffered saline 3. Infected red cells - poly agg – less obvious – does not occur at 37C- true group can be done at 37C 85
  • 86. Cause of False negative reaction  1 Use of impotent sera  Loss of potency result if sera are left at RT or stored frozen in large volume  2. No recognition of lysis  Inspected for lysis 86